Rahul Bhambri

Artificial intelligence–enabled tools in cardiovascular medicine: A survey of current use, perceptions, and challenges

Alexander Schepart, Arianna Burton, Larry Durkin et al. · Cardiovascular Digital Health Journal · 2023 · 34 citations · Full text

Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term extension studies

Mark H. Rozenbaum, Andrea García, Daniel Grima et al. · European Heart Journal - Quality of Care and Clinical Outcomes · 2021 · 29 citations · Full text

Estimating the health benefits of timely diagnosis and treatment of transthyretin amyloid cardiomyopathy

Mark H. Rozenbaum, Samuel Large, Rahul Bhambri et al. · Journal of Comparative Effectiveness Research · 2021 · 19 citations · Full text

Rivaroxaban (xarelto) for the prevention of thromboembolic disease: an inside look at the oral direct factor xa inhibitor.

Younos Abdulsattar, Rahul Bhambri, Anna Nogid · PubMed Central · 2009 · 16 citations

Thrombosis, Pulmonary Embolism, Venous Thrombosis +15

Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy

Mark H. Rozenbaum, Diana Tran, Rahul Bhambri et al. · American Journal of Cardiovascular Drugs · 2022 · 13 citations · Full text